Agendia And Agilent Announce Plans To Jointly Develop New Diagnostic Tests, Extend Supply Agreement
AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests.
Source: science20.com